| Literature DB >> 25098570 |
Martin Sivera1, Libor Kvitek2, Jana Soukupova2, Ales Panacek2, Robert Prucek2, Renata Vecerova3, Radek Zboril2.
Abstract
The potential for application of any nanoparticles, including silver nanoparticles (AgNPs), is strongly dependent on their stability against aggregation. Therefore, improvement of this parameter is a key task, especially in the case of AgNPs, because a correlation between size and biological activity has been demonstrated. In the present work, a natural stabilizer, gelatin, was investigated for the stabilization of AgNPs in an aqueous dispersion. The particles were prepared via a modified Tollens process, and the gelatin modifier was added prior to the reducing agent. The stability against aggregation of the AgNPs prepared by this method was more than one order of magnitude higher (on the basis of the critical coagulation concentration (CCC)) than that of AgNPs prepared via a similar method but without the assistance of gelatin. Their high stability against aggregation was confirmed over wide pH range (from 2 to 13) in which the particles did not exhibit rapid aggregation; such stability has not been previously reported for AgNPs. Additionally, gelatin not only fulfills the role of a unique stabilizer but also positively influences the modified Tollens process used to prepare the AgNPs. The diameter of the gelatin-modified AgNPs was substantially smaller in comparison to those prepared without gelatin. The polydispersity of the dispersion significantly narrowed. Moreover, the gelatin-stabilized AgNPs exhibited long-term stability against aggregation and maintained high antibacterial activity when stored for several months under ambient conditions.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25098570 PMCID: PMC4123891 DOI: 10.1371/journal.pone.0103675
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1TEM images and corresponding particle size distribution histograms of AgNPs reduced by maltose (a), ascorbic acid (b), and sodium borohydride (c) in the presence of gelatin.
The concentration of gelatin was 0.025% (w/w).
Average values of AgNP diameter determined from DLS measurements and from TEM images.
| Gelatin concentration [% w/w] | Average particle diameter [nm] | Average particle diameter [nm] | |
| Maltose | 0.00025 | 43 | 30.4 |
| 0.00250 | 50 | 22.8 | |
| 0.02500 | 62 | 9.3 | |
| Ascorbic acid | 0.025 | 70 | 38.3 |
| 0.250 | 76 | 32.7 | |
| 2.500 | 280 | 17.9 | |
| Sodium borohydride | 0.025 | 93 | 5.0 |
| 0.250 | 133 | 6.5 | |
| 2.500 | 300 | 5.3 |
*1determined from DLS;
*2determined from TEM.
AgNPs were prepared via a modified Tollens process using various reducing agents in the presence of gelatin.
Figure 2UV/vis absorption spectra of AgNPs reduced by maltose (a) and sodium borohydride (b) and modified by gelatin at a concentration of 0.01% (w/w) in the reaction system.
Figure 3UV/vis absorption spectra of the unmodified (a) and gelatin-modified (b) AgNPs reduced by maltose at various pH values.
Figure 4Minimum inhibitory concentrations of the AgNPs reduced by maltose, ascorbic acid, and sodium borohydride in systems influenced by the presence of gelatin at a concentration of 0.05% (w/w).
Determined after one week (a) and after three months (b).